Vertex Pharmaceuticals said on Tuesday its next-generation cystic fibrosis treatment has won European Union approval for a ...

With its blockbuster Trikafta set to lose patent protection within the decade, Vertex is strengthening its cystic fibrosis ...

Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated ...

A scientific team has unlocked a new way to treat serious lung conditions by using specially designed nanoparticles to ...

VRTX secures EU approval for Alyftrek, a next-in-class triple combination regimen for treating people with CF aged six years ...

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for ALYFTREK® ...

At 7 years old, Morgan Barrett was diagnosed with cystic fibrosis. Prior to her diagnosis, she struggled to gain weight ...

Affordable access to life-changing treatment for cystic fibrosis will be expanded to more Australians with a change to the ...

A small group of Australians with the rarest kinds of cystic fibrosis – fewer than 200 people – will, for the first time, ...

A family who know how devastating a cystic fibrosis diagnosis can be recently tackled an assault course in support of poorly ...

Vertex Pharmaceuticals (VRTX) on Tuesday announced that the European Commission has granted approval for Alyftrek for the ...

North Carolina man created a foundation to help other patients navigate expenses of an unexpectedly longer life ...